UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 315

Sortiert nach

Plasma processing conditions substantially influence circulating microRNA biomarker levels

PloS one, 2013-06, Vol.8 (6), p.e64795-e64795

2013

Link zum Volltext

Verfügbarkeit prüfen

Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition

Science signaling, 2019-02, Vol.12 (567)

2019

Link zum Volltext

Verfügbarkeit prüfen

Anti-PD-1 and Anti-PDL-1 Monoclonal Antibodies Causing Type 1 Diabetes

Diabetes care, 2015-09, Vol.38 (9), p.e137-e138

2015

Link zum Volltext

Verfügbarkeit prüfen

A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer

Clinical cancer research, 2020-02, Vol.26 (4), p.837-845

2020

Link zum Volltext

Verfügbarkeit prüfen

Cisplatin and Radiotherapy With or Without Erlotinib in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Phase II Trial

Journal of clinical oncology, 2013-04, Vol.31 (11), p.1415-1421

2013

Link zum Volltext

Verfügbarkeit prüfen

Validation and Implementation of Targeted Capture and Sequencing for the Detection of Actionable Mutation, Copy Number Variation, and Gene Rearrangement in Clinical Cancer Specimens

The Journal of molecular diagnostics : JMD, 2014, Vol.16 (1), p.56-67

2014

Link zum Volltext

Verfügbarkeit prüfen

MYCN drives chemoresistance in small cell lung cancer while USP7 inhibition can restore chemosensitivity

Genes & development, 2020-09, Vol.34 (17-18), p.1210-1226

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Daily Sunitinib in FDG-PET-Positive, Iodine-Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of the Thyroid with Functional Imaging Correlation

Clinical cancer research, 2010-11, Vol.16 (21), p.5260-5268

2010

Link zum Volltext

Verfügbarkeit prüfen

Neratinib, an Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor: Results of a Phase II Trial in Patients With Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2010-06, Vol.28 (18), p.3076-3083

2010

Link zum Volltext

Verfügbarkeit prüfen

Phase Ib Trial of the Toll-like Receptor 8 Agonist, Motolimod (VTX-2337), Combined with Cetuximab in Patients with Recurrent or Metastatic SCCHN

Clinical cancer research, 2017-05, Vol.23 (10), p.2442-2450

2017

Link zum Volltext

Verfügbarkeit prüfen

A phase 1, dose-escalation study of PF-06664178, an anti-Trop-2/Aur0101 antibody-drug conjugate in patients with advanced or metastatic solid tumors

Investigational new drugs, 2018-10, Vol.36 (5), p.836-847

2018

Link zum Volltext

Verfügbarkeit prüfen

Phase I Results from a Study of Crizotinib in Combination with Erlotinib in Patients with Advanced Nonsquamous Non–Small Cell Lung Cancer

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.145-151

2017

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory Gene Polymorphisms in Lung Cancer Susceptibility

Journal of thoracic oncology, 2018-05, Vol.13 (5), p.649-659

2018

Link zum Volltext

Verfügbarkeit prüfen

Value‐Based Care in Lung Cancer

The oncologist (Dayton, Ohio), 2016-08, Vol.21 (8), p.903-906

2016

Link zum Volltext

Verfügbarkeit prüfen

Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma

Journal for immunotherapy of cancer, 2020-07, Vol.8 (2), p.e001009

2020

Link zum Volltext

Verfügbarkeit prüfen

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes

The Annals of thoracic surgery, 2008-11, Vol.86 (5), p.1632-1639

2008

Link zum Volltext

Verfügbarkeit prüfen

Mocetinostat in Combination With Durvalumab for Patients With Advanced NSCLC: Results From a Phase I/II Study

Clinical lung cancer, 2023-05, Vol.24 (3), p.218-227

2023

Link zum Volltext

Verfügbarkeit prüfen

Sarcoidosis Presenting as Isolated Anasarca and Hypercalcemia

The American journal of medicine, 2019-01, Vol.132 (1), p.e13-e14

2019

Link zum Volltext

Verfügbarkeit prüfen

Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent/metastatic head and neck cancer (RMHNSCC) patients

Cancer medicine (Malden, MA), 2022-11, Vol.11 (22), p.4104-4111

2022

Link zum Volltext

Verfügbarkeit prüfen

Estrogen signaling in lung cancer: an opportunity for novel therapy

Cancers, 2012-09, Vol.4 (4), p.969-988

2012

Link zum Volltext

Verfügbarkeit prüfen

Impact of Clinical Trial Participation on Survival of Patients with Metastatic Non-Small Cell Lung Cancer

Clinical lung cancer, 2021-11, Vol.22 (6), p.523-530

2021

Link zum Volltext

Verfügbarkeit prüfen

An Open-Label, Phase II Study of the Polo-like Kinase-1 (Plk-1) Inhibitor, BI 2536, in Patients with Relapsed Small Cell Lung Cancer (SCLC)

Lung cancer (Amsterdam, Netherlands), 2017-02, Vol.104, p.126-130

2017

Link zum Volltext

Verfügbarkeit prüfen

Timing of postoperative radiation therapy and survival in resected salivary gland cancers: Long-term results from a single institution

Oral oncology, 2021-12, Vol.123, p.105626-105626, Article 105626

2021

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial of eribulin mesylate in recurrent or metastatic salivary gland malignancies

Head & neck, 2018-03, Vol.40 (3), p.584-589

2018

Link zum Volltext

Verfügbarkeit prüfen

Long term follow-up of neoadjuvant chemotherapy for non-small cell lung cancer (NSCLC) investigating early positron emission tomography (PET) scan as a predictor of outcome

BMC cancer, 2019-01, Vol.19 (1), p.70-9, Article 70

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 315

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(256)
Mit Volltextzugriff
(278)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(314)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

Science & Technology
(142)
Life Sciences & Biomedicine
(126)
Humans
(94)
Male
(55)
Female
(51)
Oncology
(37)
Middle Aged
(31)
Aged
(30)
Adult
(26)
Biological And Medical Sciences
(26)
Treatment Outcome
(20)
Animals
(18)
Medical Sciences
(18)
Nonfiction
(16)
Patients
(16)
Lung Neoplasms - Drug Therapy
(15)
Retrospective Studies
(13)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(12)
Carcinoma, Non-Small-Cell Lung - Pathology
(12)
Gastroenterology & Hepatology
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Plasma processing conditions substantially influence circulating microRNA biomarker levels

Targeting NOTCH activation in small cell lung cancer through LSD1 inhibition

Anti-PD-1 and Anti-PDL-1 Monoclonal Antibodies Causing Type 1 Diabetes

A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer

Cisplatin and Radiotherapy With or Without Erlotinib in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Phase II Trial

Validation and Implementation of Targeted Capture and Sequencing for the Detection of Actionable Mutation, Copy Number Variation, and Gene Rearrangement in Clinical Cancer Specimens

MYCN drives chemoresistance in small cell lung cancer while USP7 inhibition can restore chemosensitivity

Phase II Study of Daily Sunitinib in FDG-PET-Positive, Iodine-Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of the Thyroid with Functional Imaging Correlation

Neratinib, an Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor: Results of a Phase II Trial in Patients With Advanced Non–Small-Cell Lung Cancer

Phase Ib Trial of the Toll-like Receptor 8 Agonist, Motolimod (VTX-2337), Combined with Cetuximab in Patients with Recurrent or Metastatic SCCHN

A phase 1, dose-escalation study of PF-06664178, an anti-Trop-2/Aur0101 antibody-drug conjugate in patients with advanced or metastatic solid tumors

Phase I Results from a Study of Crizotinib in Combination with Erlotinib in Patients with Advanced Nonsquamous Non–Small Cell Lung Cancer

Inflammatory Gene Polymorphisms in Lung Cancer Susceptibility

Value‐Based Care in Lung Cancer

Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes

Mocetinostat in Combination With Durvalumab for Patients With Advanced NSCLC: Results From a Phase I/II Study

Sarcoidosis Presenting as Isolated Anasarca and Hypercalcemia

Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent/metastatic head and neck cancer (RMHNSCC) patients

Estrogen signaling in lung cancer: an opportunity for novel therapy

Impact of Clinical Trial Participation on Survival of Patients with Metastatic Non-Small Cell Lung Cancer

An Open-Label, Phase II Study of the Polo-like Kinase-1 (Plk-1) Inhibitor, BI 2536, in Patients with Relapsed Small Cell Lung Cancer (SCLC)

Timing of postoperative radiation therapy and survival in resected salivary gland cancers: Long-term results from a single institution

Phase II trial of eribulin mesylate in recurrent or metastatic salivary gland malignancies

Long term follow-up of neoadjuvant chemotherapy for non-small cell lung cancer (NSCLC) investigating early positron emission tomography (PET) scan as a predictor of outcome

Suchergebnisse filtern